cGxP.wire https://validator.w3.org/feed/docs/rss2.html Alkermes Reports Strong Phase 2 Data for Narcolepsy Drug Janux Therapeutics Doses First Patient in JANX014 Study Mapi Pharma GA Depot Shows Strong MS Progression Control AIM ImmunoTech Advances Ampligen Phase 3 Cancer Trial MAIA Activates U.S. Site for Phase 2 Lung Cancer Trial Khondrion Doses First Patient in Phase 3 KHENERFIN Study PharmaTher Peptide Policy Boosts Microneedle Strategy PDS Biotech Reports Breakthrough Phase 2 mCRC Results Neurelis Shows Strong Seizure Control Data for VALTOCO at AAN Fate Therapeutics FT839 CAR T Shows Strong Preclinical Data Boehringer Ingelheim Zongertinib Shows Strong NSCLC Results Foundation Medicine Expands MRD Platform with SAGA Deal AIRS Medical SwiftMR Gains FDA Clearance for MRI AI Interna, Daiichi Sankyo Partner on Drug Delivery Tech Geminii Shows Promising NSCLC Data for Bioelectronic Therapy Covalon Advances Infection Prevention and Wound Care Leadiant Biosciences Secures Canada Approval for Cysklar Aligos Therapeutics Gains Fast Track for HBV Drug AOP Health Wins FDA Approval for Rapiblyk in Pediatric SVT BioVersys Starts Phase 3 BV100 Pneumonia Trial Radical Catheter Gains FDA Clearance for 6F Device Telix Doses First Patient in Phase 3 Glioblastoma Trial LEO Pharma Gains FDA sNDA Acceptance for ANZUPGO Aligos-Amoytop $445M HBV Licensing Deal Expands Access Clarity Signs Deal to Boost Prostate Cancer Imaging Supply XellSmart Advances Phase 2 Parkinson’s Cell Therapy Trial Eli Lilly to Acquire CrossBridge Bio for ADC Platform Tempus AI, Predicta Expand Genomics Test for Blood Cancer Cala Health Gains FDA Clearance for kIQ Plus Device Precision BioSciences Expands ELIMINATE-B Trial in EU Organon VTAMA Cream Gains Strong AAD Guideline Support Dogwood Secures FDA IND Nod for SP16 Pain Therapy Immutep Secures FDA Orphan Status for Efti in Sarcoma ARS Pharma Wins Canada Nod for Needle-Free Epinephrine Boehringer Introduces LENZELTA Vaccine for Mastitis Control TOBY Gains FDA Breakthrough Status for MCED Test Mabwell Advances SST001 PET Tracer to Phase I Trial Bavarian Nordic Wins Swiss Approval for Chikungunya Vaccine Partner Therapeutics Files sBLA for BIZENGRI in CCA Apotex Secures FDA Approval for Generic Infuvite Injection Protaryx Wins FDA 510(k) Clearance for Cardiac Device Avanos to Be Acquired by AIP in $1.27B Deal GlycoNex Secures PMDA Nod for GNX1021 Phase 1 Trial Savara Inc. Gets FDA Extension for Molgramostim Review Revolution Medicines Reports Phase 3 Survival Gain PDAC Neurocrine Shows INGREZZA Persistence Edge in TD Study Boehringer Ingelheim, Zai Lab Advance DLL3 Cancer Trial SynOx Phase 3 Study Shows TGCT Treatment Benefit BioOra and Cincinnati Advance CAR-T Therapy in Leukemia City of Hope Unveils AI and Cancer Breakthroughs at AACR